Evidence map›Paper›PMID 35755455›Full record

ArticleIJID regions2022

Prevalence of non-tuberculous mycobacteria among previously treated TB patients in the Gulf of Guinea, Africa.

B D Thumamo Pokam, D Yeboah-Manu, S Ofori, P W Guemdjom, P M Teyim, L Lawson, D Amiteye, N Y Yhiler, I C Djuikoue, A E Asuquo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

B D Thumamo PokamDepartment of Medical Laboratory Science, University of Buea, Buea, Cameroon.
D Yeboah-ManuDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.
S OforiDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.
P W GuemdjomDepartment of Public Health, University of Buea, Buea, Cameroon.
P M TeyimDouala Tuberculosis Reference Laboratory, Littoral Region, Cameroon.
L LawsonZankli Medical Centre, Utako, Abuja, Nigeria.
D AmiteyeDepartment of Biomedical Engineering, All Nations University College, Koforidua, Ghana.
N Y YhilerDepartment of Medical Laboratory Science, University of Buea, Buea, Cameroon.
I C DjuikoueMicrobiology Department, Faculty of Health Sciences, Université des Montagnes, Bangangte, Cameroon.
A E AsuquoDepartment of Medical Laboratory Science, College of Medicine, University of Calabar, Calabar, Nigeria.
University of Ghana · GHUniversity of Buea · CMAll Nations University · GHUniversité des Montagnes · CMUniversity of Calabar · NGZankli Medical Centre · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Differentiation between non-tuberculous mycobacteria Methods: A collection of 503 isolates (158 from Cameroon, 202 from Nigeria and 143 from Ghana) obtained from solid and liquid cultures were analysed. The isolates were tested for drug susceptibility, and MTBC were confirmed using IS Results: Overall, the prevalence of NTM was 16/503 (3.2%), distributed as 2/202 (1%) in Nigeria, 2/158 (1.3%) in Cameroon and 12/143 (8.4%) in Ghana. The main NTM isolates included 5/16 (31.3%) Conclusion: NTM were mainly found among individuals with unsuccessful treatment. This highlights the need for mycobacterial species differentiation using rapid molecular tools for appropriate case management, as most are resistant to routine first-line antimycobacterials.

Indexed as

Drug resistancehsp65 sequencingNTMRetreatment patientsWest/Central Africa

Identifiers

PMID35755455
PMCPMC9216630
OpenAlexW4280505536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.